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a b s t r a c t
Peroxisomal ABC transporters of animals and fungi are ‘‘half-size’’ proteins which dimerise to form
a functional transporter. However, peroxisomal ABC transporters of land plants are synthesised as a
single polypeptide which represents a fused heterodimer. The N- and C-terminal pseudo-halves of
COMATOSE (CTS; AtABCD1) were expressed as separate polypeptides which bound Pex19 in vitro
and targeted independently to the peroxisome membrane in yeast, where they were stable but
not functional. When co-expressed, the pseudo-halves were fully functional as indicated by ATPase
activity and rescue of the pxa1pxa2D mutant for growth on oleate. The functional signiﬁcance of
heterodimer asymmetry is discussed.
Structured summary of protein interactions:
PEX19-1 binds to CTS-N by pull down (View Interaction)
PEX19-1 binds to CTS-C by pull down (View Interaction)
PEX19-2 binds to CTS-N by pull down (View Interaction)
PEX19-2 binds to CTS-N by pull down (View Interaction)
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
1. Introduction
ABC transporters couple ATP hydrolysis to the trans-membrane
movement of a wide range of substrates. All ABC transporters com-
prise four functional domains: two sets of primarily a-helical trans-
membrane domains (TMDs) which associate to form the transport
pathway for the substrate and two nucleotide binding domains
(NBDs) which dimerise and form two composite ATP binding sites
at the dimer interface.
Peroxisomes from all eukaryotes contain at least one member of
the ABC subfamily D which transports lipophilic/amphipathic
substrates from the cytosol into the peroxisome for b-oxidation.
Comatose (CTS; AtABCD1, also known as AtPXA1 and PED3) is a full
size peroxisomal ABC transporter fromArabidopsiswith the domain
organisation [TMD-NBD-TMD-NBD] [1–3]. Thus CTS can be consid-
ered to be a fused heterodimer consisting of two homologous but
distinct halves. This gene structure is found in all land plants includ-
ingbryophytes but is not present in algae, suggesting that this fusion
happened once in the land plant lineage more than 450 Ma ago
(Fig. 1). In contrast, animal and fungal peroxisomal ABC transporters
are all half transporters with the organisation [TMD-NBD] that have
todimerise for activity [4].MammalianABCDproteinsare functional
as homodimers, but in Saccharomyces cerevisiae, the half transport-
ers Pxa1p and Pxa2p heterodimerise to transport long chain acyl
CoAs [5,6].We have shown recently that CTS targets to peroxisomes
when expressed in oleate-grown S. cerevisiae and has the ability to
complement the yeast pxa1 pxa2D mutant for b-oxidation of fatty
acids [7].
Since only land plants have peroxisomal transporters with the
fused heterodimer conﬁguration, but this arrangement is functional
in S. cerevisiae, we investigated the targeting and functionality of the
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twoCTS pseudohalf transporters CTS-N and CTS-C fromArabidopsis
when expressed in yeast.
2. Materials and methods
2.1. Growth of yeast
Yeast strains were grown as described in [7]. Yeast strains are
given in Table 1.
2.2. Pull-down assays
AtPEX19-1 was ampliﬁed with primer pair FT119/FT120 (Table
S1), restricted with Bam HI/Not I and cloned in the corresponding
sites of pGEX-4T-3 (GE Healthcare). AtPEX19-2 was ampliﬁed with
primer pair FT121/FT122, restricted with Sal I/Not I and cloned in
the corresponding sites of pGEX-4T-3. Expression and puriﬁcation
of glutathione S-transferase (GST) fusion proteins was carried out
as described in [8]. CTS-N and CTS-C were ampliﬁed from plasmid
H1A6T7 using primer pairs FT187/FT189 and FT190/FT188 respec-
Fig. 1. Phylogenetic analysis of ABC family D transporters. Analysis by the Maximum Likelihood method was performed as described in Supplementary data. Upper and lower
case letters at the beginning of protein names indicate abbreviated Latin binomial names for species, as detailed in the species key (Table S2). Subfamily members within each
species are classiﬁed according to [18].
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tively, restricted with Nco I and Sma I and cloned into the corre-
sponding sites of pIVEX1.3 (www.5prime.com). In vitro translation
was carried out using a wheat germ lysate (5PRIME kit), according
to manufacturer’s instructions. Aliquots were removed for immu-
noblot analysis (typically 10–20% input) and equal volumes of
the remainder were used for pull-down reactions using GST-At-
PEX19-1, GST-AtPEX19-2 or GST alone. Pull-down assays were per-
formed as described in [8], except that proteins were detected by
immunoblotting with an anti-penta-His antibody (Qiagen).
2.3. Plasmids for yeast expression
The ORF of AtPEX19-1 was ampliﬁed by PCR from plasmid pHD-
1PEX19-1 [9] using primer pair AtPEX19F/AtPEX19R (Table S1) and
cloned into pRS415-met25 as a Bam HI-Eco RI fragment. AtPEX19-1
and ScPex19 were ampliﬁed from pHD-1PEX19_1 and pKat61 [10]
with primer pairs FT163/FT137 and FT160/161, respectively and re-
stricted with BamHI/Sal I. AtPEX19-2 was ampliﬁed from cDNA clone
U13401 (Arabidopsis Biological Resource Center, Ohio) with primer
pair FT138/FT139, and restricted with Bgl II/Sal I. The fragments were
ligated into the Bam HI/Sal I sites of both pRS416/GPD and pRS415/
met25. Details of primer pairs are given in Table S1. To generate con-
structs for the expression of pseudo-half transporters, the N-terminal
half of CTS (encoding amino acids 1–676, designated ‘‘CTS-N’’) and
the C-terminal half (‘‘CTS-C’’, encoding amino acids 677–1337) were
ampliﬁed from CTS/pRS416-GPD [7] using primer pairs CTSAF/CTSAR
and CTSBF/CTSBR, respectively (Table S1). All products were restricted
with Bam HI and Eco RI and ligated into pRS416-GPD [7] and also
pRS415/met25. Similarly, for complementation experiments, CTS-N
and CTS-C were ampliﬁed using primer pairs FT167/FT168 and
FT169/FT170, respectively. Products were restricted with Bam HI and
Sal I and ligated into pEL30 and pIJL30.
2.4. Statistical analysis
Data were expressed as mean SI ± 95% CL, where 95% CL was
determined according to the formula: 95% CL = mean ± (t  SEM),
where n = number of samples, t = value of the Student t-distribu-
tion at (n1) degrees of freedom and SEM is the standard error
of the mean. All the statistical analysis and calculations were done
using Origin 8.0 Data Analysis and Graphing Software statistical
package and Windows

Microsoft Excel.
Table 1
Yeast strains used in this study.
BSL1-11B (WT) MATa, lys2D0, his4D519, Ura3D0, leu2D2 [19]
BSL1-11B (pxa1D) MATa, lys2D0, his4D519, Ura D0, leu2D2, YPL147w::kanMX4 [7]
BY4742 (WT) Mat a; his3D1; leu2D00; lys2D0; ura3D0 [20]
BY4742 (pex19D) Mat a; his3D1; leu2D00; lys2D0; ura3D0; YDL065c::kanMX4 [20]
BJ1991 Mata, leu2, trp1, ura3-251, prb1-112,pex4-3 [5]
BJ1991 (pxa1,2D) Mata, leu2, trp1, ura3-251, prb1-112,pex4-3; YPL147w::LEU2;YKL188c::kanMX4 [5]
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Fig. 2. Role of Pex19 in peroxisomal targeting of CTS. (A) Predicted and experimentally-veriﬁed Pex19 binding sites in members of the ABCD family. An algorithm developed
for detecting Pex19p binding sites in yeast PMPs was used to detect such binding sites in human, yeast [10] and plant PMPs (H. Rottensteiner, personal communication);
scores are given in arbitrary units. An alignment of the Pex19p binding sites in members of the ABC sub family D is presented. Sites marked with an asterisk have been shown
to be functional in Pex19 binding assays [12]. (B) Interaction of CTS pseudo-half molecules with Pex19 in vitro. AtPEX19-1 and AtPEX19-2 were expressed as GST fusion
proteins in E. coli. Puriﬁed fusion proteins (or GST only, negative control) were immobilised on glutathione beads and incubated with in vitro translated histidine-tagged CTS
pseudo-half molecules (CTS-N and CTS-C). Interacting proteins were eluted with SDS–PAGE buffer and separated in a 12% acrylamide denaturing gel. Labelled proteins were
visualised by immunoblotting with an anti-penta-His antibody. 20% input: 20% of the CTS proteins used in the pull-down experiment. Result representative of three
independent experiments.
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2.5. Miscellaneous
Peroxisome isolation, carbonate extractions, ATPase assays,
immunoblotting and complementation for growth on oleate med-
ium were performed as described in [7] and [9]. Pex19 binding site
prediction and homology modelling of CTS are described in [10]
and [11], respectively.
3. Results and discussion
3.1. The two halves of CTS contain independent binding sites for both
Arabidopsis and Saccharomyces Pex19
Pex19p is a universal and essential factor for the correct locali-
sation and insertion of peroxisome membrane proteins. Although
there is debate over the exact role of Pex19p, recognition of perox-
isome membrane proteins is central to all the proposed functions.
Pex19p binding sites in a number of PMPs are short helical motifs
that overlap with the peroxisome targeting signal [10]. A Pex19p
binding motif predictor has been developed and used to identify
and experimentally verify a Pex19p binding site in human ALDP
(HsABCD1) which was functional in both human and S. cerevisiae
[10,12]. Analysis of CTS with the Pex19p binding site predictor re-
vealed ﬁve potential Pex19p binding sites at amino acids 105–119,
173–187, 759–773, 795–809 and 820–834. Based on the scores
shown in Fig. 2A, there is a major site in both the N-(CTS-N) and
C-(CTS-C) terminal parts of CTS as well as one and two minor sites
in these regions, respectively. These sites all share features with
those from other ABCD subfamily proteins, especially the predom-
inance of hydrophobic amino acid side chains, the absence of pro-
line and the under representation of negatively charged amino
acids.
CTS was expressed as two pseudo-half transporters
CTS-N (1–676) and CTS-C (677–1337), dividing the protein just
after NBD1, at the beginning of the predicted ﬂexible linker region
[7,11], and the ability of each half to interact with different Pex19
isoforms in vitro was examined in a pull-down assay (Fig. 2B). CTS-
N and -C were expressed by in vitro transcription and translation,
incubated with puriﬁed GST-Pex19 fusion proteins and the Pex19
protein recovered by afﬁnity isolation on glutathione agarose
beads. GST alone was used as a negative control. Low or very low
levels of non-speciﬁc binding to the GST control were seen for
CTS-N and CTS-C, but much greater amounts (>20% of input) of
CTS-N and CTS-C re-isolated with AtPEX19-1, AtPEX19-2 (Fig. 2B)
and ScPex19p (Figure S1), indicating that both halves of the protein
can interact with Pex19 from both species. The presence of Pex19
binding sites in both halves of the protein likely reﬂects their dis-
tant evolutionary history as separate proteins (see phylogenetic
tree in Fig 1). The fact that they have apparently retained function-
ality over millions of years since the divergence of land plants, sug-
gests that they might be functionally important and that Pex19
interacts with full-length CTS at more than one site, perhaps to
maintain solubility prior to insertion in the peroxisomal mem-
brane. Large membrane proteins are difﬁcult for the cell to fold
and are often subject to a high rate of misfolding, thus chaperones
would be selected for. This has been very well documented for an-
other ‘‘full-length’’ ABC transporter, the cystic ﬁbrosis transmem-
brane conductance regulator, CFTR, which is subject to multiple
quality control mechanisms [13].
3.2. Arabidopsis PEX19 cannot complement the S. cerevisiae pex19D
mutant for growth on oleate
Since CTS can be recognised by ScPex19p and since correct tar-
geting of human [12] and plant [7] PMPs has been demonstrated in
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Fig. 3. Arabidopsis PEX19 does not complement the yeast pex19D mutant for
growth on oleate. (A) Growth of wild type (WT) and pex19D cells on solid oleate
medium. pex19D cells were transformed with AtPEX19-1/pRS416, AtPEX19-2/
pRS415, both Arabidopsis Pex19 isoforms, ScPex19/pRS416 or vectors lacking
insert. Complementation was not observed when pex19D cells were transformed
with either AtPEX19-1 or AtPEX19-2 alone (not shown). (B) Extracts from cells in
(A) separated on a 4–12% SDS–PAGE gradient gel and immunoblotted with a
polyclonal antiserum raised against AtPEX19-1 but which also recognises AtPEX19-
2 ([9]; upper panel) or stained with Coomassie Brilliant Blue (lower panel). The
mobilities of marker proteins of known mass (kDa) are indicated on the right hand
side of the immunoblot. The different levels of apparent expression likely reﬂect the
strength of the promoters in pRS416 and pRS415.
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S. cerevisiae, we tested whether Arabidopsis PEX19 could comple-
ment the S. cerevisiae pex19D mutant for growth on oleate. The
two PEX19 isoforms of Arabidopsis, PEX19-1 and PEX19-2, are
79% identical at the amino acid level but share only ca. 25% identity
to ScPex19p [9]. RNAi down regulation of these two Pex19 iso-
forms in Arabidopsis suggested they are not completely function-
ally redundant [14]. We expressed AtPEX19-1 and AtPEX19-2
independently and together in the S. cerevisiae pex19D mutant
(Fig. 3A). Neither protein alone or in combination was able to res-
cue the oleate non-utilisation (onu) phenotype of the pex19D mu-
tant, despite both proteins being expressed at detectable levels
(Fig. 3B). This may be because the ability to complement the onu
phenotype is a very stringent test of conservation of function and
requires not only recognition of the targeting signals of all PMPs
necessary (directly or indirectly) for oleate metabolism, but also
rescue of all Pex19 functions, including the capacity to be modiﬁed
by the yeast farnesyl transferase and to interact productively with
yeast Pex3p.
3.3. CTS-N and CTS-C target independently to peroxisomes and are
correctly integrated into peroxisome membranes
CTS-N and CTS-C were expressed separately in yeast and oleate-
grown cultures were subjected to fractionation on Optiprep™ gra-
dients to prepare peroxisome- and mitochondria-enriched frac-
tions, which were subsequently analysed by SDS PAGE and
immunoblotting (Fig. 4). Good separation between the organellar
fractions was demonstrated by the enrichment of thiolase (perox-
isomal marker) and porin (mitochondrial marker) in the appropri-
ate fractions (Fig. 4A, lower two panels). Both CTS-N and CTS-C
were almost exclusively detected in the peroxisome fraction
(Fig. 4A upper panel), with a small amount being detected in the
mitochondrial fraction. When the peroxisome membrane is limit-
ing in yeast cells (for example on lactate medium or in the pex19D
background), CTS mistargeted and was detected in the mitochon-
drial fraction (data not shown). CTS-N and CTS-C were found to
be more stable than the full length CTS, which is subject to exten-
sive proteolysis within the linker region joining the two pseudo
halves [7]. This is in contrast to Pxa1p, which is unstable in the
pxa2D background, although Pxa2p is stable in the absence of
Pxa1p [15]. Similarly, the mammalian ER-located ABC half-trans-
porter, TAP2, is unstable in the absence of its partner TAP1 [16].
Both CTS-N and CTS-C were not extractable from the membranes
by alkaline sodium carbonate treatment, consistent with the fact
that they contain multiple transmembrane helices and are presum-
ably integrated into the membrane (Fig. 4B). These results demon-
strate that each pseudo half transporter contains all the necessary
information to be recognised and inserted into peroxisome mem-
branes by the heterologous host cell machinery.
3.4. Co-expression of CTS-N and CTS-C is required for function
We investigated whether CTS-N and CTS-C are functional when
expressed in yeast. Neither protein complemented the onu pheno-
type of the pxa1,2D mutant when expressed alone, but when ex-
pressed together permitted growth on oleate comparable to that
obtained with full-length CTS (Fig. 5A). We then tested whether
the pseudo-halves could form homodimers or heterodimers with
ATPase activity. ATPase activity was measured in peroxisomes iso-
lated from strains expressing full length CTS, CTS-N and CTS-C sep-
arately, CTS-N and CTS-C co-expressed, and empty vector
transformed cells. Peroxisomes from cells co-expressing CTS-N
and CTS-C had CTS-speciﬁc basal ATPase activity (as measured in
[7]) which was almost as high as that of peroxisomes containing
the full length CTS. In contrast, peroxisomes from cells where
CTS-N and CTS-Cwere expressed alone had nomore ATPase activity
than control cells. Thus CTS-N and CTS-C can assemble to form an
active heterodimer. CTS-N and CTS-C alone are either unable to
homodimerise, or form an inactive homodimer.
As NBDs dimerise during the transport cycle, the two ATP bind-
ing sites are composites, comprising residues from both NBDs.
Each ATP site is made up of theWalker A, Walker B and Switch mo-
tif (H-loop) from one NBD and the signature motif and D loop from
the other NBD. NBD1 of CTS shows conservation of all functionally
important residues in the Walker A, Walker B and Switch or ‘H’
loop and mutagenesis shows that Walker A and B residues of
NBD1 are essential for function in vivo [11]. In contrast, NBD2
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Fig. 4. CTS N- and C-terminal pseudo-half molecules target to peroxisomes
independently and are integrated into the peroxisome membrane. (A) BLS1-11B
cells transformed with the CTS-N/pRS416-GPD or CTS-C/pRS416-GPD were grown
on WOYD medium and transferred to the oleate medium for peroxisome induction.
A light mitochondrial fraction was prepared and separated on an iodixanol density
gradient. The fractions corresponding to the peroxisomes (P) and mitochondria (M)
were separated by SDS–PAGE in a 7.5% gel (30 lg of protein/lane) and immuno-
blotted with antibodies raised against CTS, thiolase (peroxisomal marker), and
porin (mitochondrial marker) [7]. The fractions corresponding to the total cell
lysate (T) and cytosol (C) were also collected and treated as above. The mobilities of
marker proteins of known mass (kDa) are indicated on the left hand side of the
ﬁgure. The upper band represents unrelated cross reaction with a mitochondrial
protein. (B) Organelles (‘‘light mitochondrial fraction’’) were isolated from oleate-
grown BLS1-11B cells transformed with the CTS-N/pRS416-GPD or CTS-C/pRS416-
GPD and were lysed in a hypotonic buffer in the presence of protease inhibitors.
Membranes were separated from soluble proteins by centrifugation at 100,000g
and then extracted with alkaline sodium carbonate buffer, pH 11.5, followed by re-
centrifugation at 100,000g. Pellet and supernatant (SN) fractions were separated by
SDS–PAGE (30 lg per lane) followed by immunoblotting with antibodies raised
against CTS. The mobilities of marker proteins of known mass (kDa) are indicated
on the left hand side of the ﬁgure.
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has Q in place of H in the Switch loop. This histidine plays a critical
role in contacting the c-phosphate of the bound ATP. Thus CTS will
have one consensus and one degenerate ATP binding site. This
asymmetry is quite common in eukaryotic ABC transporters [17
and references therein]; indeed Pxa1p and TAP1 also contain the
same H to Q substitution. In the light of this, CTS-C might be ex-
pected to be non-functional when expressed in the absence of
CTS-N. However, CTS-N contains consensus residues which con-
tribute to the ATP binding site and might be predicted to form a
catalytically active homodimer when expressed alone. The fact
that CTS-N expressed alone does not exhibit ATPase activity sug-
gests either, that it is not able to homodimerise, and/or that a
‘‘degenerate’’ ATP binding site is somehow important for the ATP-
ase catalytic cycle of CTS. Alternatively, the lack of functionality of
CTS pseudo half molecules may be related to TMD structure. A
model of CTS based on the structure of the homodimeric ABC
transporter Sav1866 predicts ‘‘domain-swapping’’, such that
TMD1 contacts NBD2 and vice versa [11]. Moreover, in the model,
a-helices from the two distinct halves of the protein are shared be-
tween the two TMDs, such that one is composed of TM helices 3–8
and the other of TM helices 1, 2, and 9–12 (Fig. 6). Within the
TMDs, the interface between the two halves of the protein involves
interactions between TM2 and 11 and between TM8 and 5. In the
homodimeric molecule Sav1866 the equivalent interactions, be-
tween TM2 of one subunit and TM5 of the other, are necessarily
identical whereas this is not the case in native CTS. For example,
a salt bridge is predicted between R834 (TM8) and D332 (TM5),
while the equivalent positions in the other TMD are occupied by
I180 (TM2) and K986 (TM11). In the CTS-C homodimer, the corre-
sponding interface would contain R834 and K986, likely resulting
in electrostatic repulsion, while in the CTS-N homodimer, the
interface would contain I180 and D332, precluding salt bridge for-
mation or the likely hydrophobic interaction between the isoleu-
cine side chain and the aliphatic portion of the lysine side chain.
Similar differences in size and/or charge are observed between a
number of other conserved interfacial residues at equivalent posi-
Fig. 6. Homology model of CTS showing domain swapping of transmembrane
helices. Modiﬁed from [11]. The N- and C-terminal halves of the CTS molecule are
coloured in green and blue, respectively. Residues R834 and D332, predicted to
form a salt bridge in the interface between the halves, are shown in space-ﬁlling
representation, as are bound AMP-PNP molecules within the NBDs.
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Y. Nyathi et al. / FEBS Letters 586 (2012) 2280–2286 2285
tions elsewhere in the two halves of the molecule. These would
likely interfere with the association between, and/or activity of,
the CTS homodimers. Conservation of a number of interfacial resi-
dues is indicative of their probable collective importance in main-
taining the interaction between the helices. In conclusion, while
there is no apparent requirement for the two halves of CTS to be
covalently joined to produce a functional molecule, both halves
are indispensable for biological activity.
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